Home › Chronic-Phase Myeloid Leukemia › Georgia
Chronic-Phase Myeloid Leukemia clinical trials in Georgia
3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in Georgia.
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1045, Augusta
- Ascentage Investigative Site #1110, Newnan
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Northside Hospital, Atlanta
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07020533A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Georgia Cancer Center at Augusta University, Augusta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT06163430From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.